Lamictal (Lamotrigine)

Lamotrigine blocks voltage‑gated sodium channels on neurons, reducing the influx of sodium ions during depolarisation. This stabilises neuronal membranes, limits excessive firing, and lowers the release of excitatory neurotransmitters such as glutamate, which underlies its antiepileptic and mood‑stabilising actions.

The prescribed dose of Lamictal is individualized by the treating clinician based on the specific indication, patient age, weight, renal function, and any concomitant medications that may affect lamotrigine metabolism. Dosage adjustments are made according to therapeutic response and tolerability.

Safety of lamotrigine in pregnancy and lactation is not fully established. Clinicians weigh potential benefits against risks, as some data suggest a modest increase in congenital malformation risk. Women who are pregnant, planning pregnancy, or breastfeeding should discuss individualized risk assessment with their healthcare provider.

To request Lamictal, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with many older antiepileptics, lamotrigine has a favourable profile for mood stabilization and a lower incidence of cognitive side effects. However, it requires a slower titration to minimise rash risk, and its plasma levels are more sensitive to enzyme‑inducing or inhibiting co‑medications.

Lamictal tablets should be stored at ambient temperature, preferably below 25 °C, in the original container to protect them from moisture and light. Keep the product out of reach of children and avoid storing in areas with high humidity or direct sunlight.

Lamictal is taken orally, usually once or twice daily, with or without food as directed by the prescriber. Tablets should be swallowed whole with water; they are not intended for crushing, chewing, or splitting unless specifically advised by a healthcare professional.

The most serious adverse events include severe skin reactions such as Stevens‑Johnson syndrome or toxic epidermal necrolysis, aseptic meningitis, and rare blood dyscrasias like agranulocytosis. Prompt medical attention is required if a rash spreads, blisters develop, or systemic symptoms such as fever or neck stiffness appear.

Lamictal is contraindicated in individuals with a known hypersensitivity to lamotrigine or any of its excipients. Caution is advised for patients with a history of severe skin reactions, those taking interacting enzyme‑inducing drugs without proper dose adjustment, and patients with uncontrolled cardiac arrhythmias.